Chad M. Robins

Companies

• Adaptive BiotechnologiesChief executive officer Jun 26, 2019 to now¹
• Adaptive BiotechnologiesChair Jun 26, 2019 to now¹
• EQRx, Inc.Board member Apr 6, 2021 to Apr 6, 2021²
• Cerevel Therapeutics Holdings, Inc.Board member Jun 4, 2020 to Jun 4, 2020³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ABAdaptive Biotechnologies ADPT2,180,518 shares⁴$52.4M at $24.01Aug 18, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 18, 2026Sold 204 shares at $25.14 of Adaptive Biotechnologies⁴
• Aug 18, 2026Sold 278,472 shares at $24.48 of Adaptive Biotechnologies⁴
• Aug 18, 2026Exercised options 278,676 shares at $6.55 of Adaptive Biotechnologies⁴
• Aug 17, 2026Sold 2,525 shares at $25.57 of Adaptive Biotechnologies⁴
• Aug 17, 2026Sold 318,799 shares at $25.08 of Adaptive Biotechnologies⁴
• Aug 17, 2026Exercised options 321,324 shares at $6.55 of Adaptive Biotechnologies⁴
• Apr 8, 2026Sold 37,263 shares at $15.19 of Adaptive Biotechnologies⁵
• Apr 6, 2026Sold 83,332 shares at $14.41 of Adaptive Biotechnologies⁵
• Mar 11, 2026Sold 329,600 shares at $13.17 of Adaptive Biotechnologies⁶
• Mar 11, 2026Sold 140,567 shares at $13.17 of Adaptive Biotechnologies⁶
• Mar 6, 2026Granted 709,220 shares of Adaptive Biotechnologies⁷
• Mar 4, 2026Granted 127,813 shares of Adaptive Biotechnologies⁷
• Mar 3, 2026Sold 2,380 shares at $16.15 of Adaptive Biotechnologies⁸
• Mar 3, 2026Sold 50,703 shares at $15.49 of Adaptive Biotechnologies⁸
• Mar 2, 2026Sold 289,024 shares at $15.82 of Adaptive Biotechnologies⁸
• Feb 27, 2026Sold 182,891 shares at $15.99 of Adaptive Biotechnologies⁸
• Feb 2, 2026Sold 124,998 shares at $18.44 of Adaptive Biotechnologies⁹
• Jan 5, 2026Sold 124,998 shares at $15.59 of Adaptive Biotechnologies¹⁰
• Dec 1, 2025Sold 124,998 shares at $18.94 of Adaptive Biotechnologies¹¹
• Nov 26, 2025Sold 35,736 shares at $19.68 of Adaptive Biotechnologies¹¹
• Nov 12, 2025Sold 1,867 shares at $15.00 of Adaptive Biotechnologies¹²
• Nov 11, 2025Sold 1,237 shares at $14.57 of Adaptive Biotechnologies¹²
• Nov 10, 2025Sold 86,161 shares at $14.73 of Adaptive Biotechnologies¹²
• Mar 6, 2025Sold 102,218 shares at $7.64 of Adaptive Biotechnologies¹³
• Mar 5, 2025Granted 247,117 shares of Adaptive Biotechnologies¹³